Disparities in delays and outcomes in patients with HER2-positive breast cancer
{{output}}
Purpose: Neoadjuvant chemotherapy (NACT) is often the preferred systemic treatment modality for advanced breast tumors. Delays in NACT initiation are associated with worse outcomes although it is unclear which patients are at the... ...
